Affordable Inhalers and Nebulizers Act of 2025
Affordable Inhalers and Nebulizers Act of 2025
Plain Language Summary
# Affordable Inhalers and Nebulizers Act of 2025 Summary **What the Bill Would Do:** The Affordable Inhalers and Nebulizers Act of 2025 aims to make respiratory medications more affordable and accessible for patients with asthma and other lung conditions. While specific provisions aren't detailed in the available information, bills with this title typically focus on reducing costs for inhalers and nebulizers—devices that deliver medication directly to the lungs—which many patients rely on daily to manage their conditions. **Who It Affects:** This legislation would primarily affect asthma patients and people with chronic respiratory diseases who use inhalers and nebulizers.
It could also impact pharmaceutical manufacturers, insurance companies, and the healthcare system more broadly by potentially changing how these medications are priced and covered. **Current Status:** The bill (HR 5278) was introduced in the 119th Congress by Representative Kweisi Mfume (D-Maryland) and is currently in committee, meaning it hasn't yet been debated or voted on by the full House of Representatives. The bill has not advanced to become law.
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.